Nicotinic Acid [EPC]

Nicotinic Acid [EPC] was reported 61746 times

Drugs of the Nicotinic Acid [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MUSCLE CRAMP 63 0.0355
1 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 35 0.0330
2 NEPHROGENIC ANAEMIA 145 0.0313
3 HAEMORRHAGIC ANAEMIA 128 0.0291
4 HYPERPARATHYROIDISM SECONDARY 64 0.0255
5 REBOUND ACID HYPERSECRETION 64 0.0211
6 BLOOD TESTOSTERONE DECREASED 140 0.0204
7 ESSENTIAL HYPERTENSION 36 0.0197
8 HIGH DENSITY LIPOPROTEIN DECREASED 51 0.0153
9 LOWER GASTROINTESTINAL HAEMORRHAGE 113 0.0153
10 PRE-EXISTING CONDITION IMPROVED 95 0.0152
11 INJECTION SITE PAPULE 69 0.0151
12 SPINAL COLUMN STENOSIS 68 0.0144
13 EXCORIATION 35 0.0138
14 BODY HEIGHT DECREASED 142 0.0133
15 WOUND COMPLICATION 45 0.0131
16 VITAMIN D DECREASED 107 0.0125
17 THROMBOPHLEBITIS SUPERFICIAL 37 0.0122
18 DIFFICULTY IN WALKING 42 0.0122
19 FAECAL INCONTINENCE 58 0.0121
20 MUSCLE FATIGUE 51 0.0120
21 RECALLED PRODUCT ADMINISTERED 112 0.0117
22 ENDOMETRIOSIS 55 0.0115
23 METABOLIC ENCEPHALOPATHY 34 0.0113
24 INITIAL INSOMNIA 114 0.0111
25 THERAPY CESSATION 563 0.0110
26 MENISCUS INJURY 67 0.0109
27 WALKING AID USER 71 0.0108
28 CAROTID ARTERY OCCLUSION 39 0.0107
29 PROSTATOMEGALY 42 0.0107
30 INTERNATIONAL NORMALISED RATIO DECREASED 43 0.0106
31 TENDON PAIN 79 0.0104
32 INCREASED TENDENCY TO BRUISE 96 0.0104
33 LACERATION 98 0.0104
34 BLOOD CALCIUM INCREASED 91 0.0104
35 VITAMIN B12 DEFICIENCY 42 0.0104
36 END STAGE RENAL DISEASE 189 0.0104
37 SINUS HEADACHE 61 0.0103
38 PRODUCT SUBSTITUTION ISSUE 591 0.0103
39 SPINAL OSTEOARTHRITIS 88 0.0100
40 DIZZINESS POSTURAL 97 0.0100
41 ATELECTASIS 96 0.0099
42 BENIGN PROSTATIC HYPERPLASIA 51 0.0099
43 INTENTIONAL DEVICE MISUSE 43 0.0097
44 INTERVERTEBRAL DISC DEGENERATION 89 0.0096
45 TRICUSPID VALVE INCOMPETENCE 76 0.0096
46 EXOSTOSIS 87 0.0095
47 LOCAL SWELLING 166 0.0095
48 SINUS CONGESTION 128 0.0095
49 LOW DENSITY LIPOPROTEIN INCREASED 73 0.0094
50 COAGULOPATHY 155 0.0093
51 PROTEIN TOTAL DECREASED 35 0.0093
52 BLOOD TRIGLYCERIDES INCREASED 164 0.0093
53 SMALL INTESTINAL OBSTRUCTION 114 0.0093
54 CORONARY ARTERY OCCLUSION 127 0.0093
55 SNORING 35 0.0092
56 PRODUCT FORMULATION ISSUE 61 0.0092
57 UPPER-AIRWAY COUGH SYNDROME 76 0.0092
58 RENAL FAILURE CHRONIC 70 0.0091
59 STOMACH DISCOMFORT 47 0.0091
60 PHARYNGOLARYNGEAL PAIN 48 0.0090
61 FULL BLOOD COUNT DECREASED 181 0.0090
62 PERONEAL NERVE PALSY 51 0.0090
63 CHOLECYSTITIS CHRONIC 60 0.0090
64 MIDDLE INSOMNIA 167 0.0089
65 DIVERTICULUM 63 0.0089
66 PELVIC PAIN 161 0.0089
67 URINE ODOUR ABNORMAL 52 0.0088
68 HAEMATOCRIT DECREASED 175 0.0088
69 DECREASED INTEREST 52 0.0088
70 INJECTION SITE NODULE 97 0.0088
71 ROTATOR CUFF SYNDROME 113 0.0088
72 SLEEP APNOEA SYNDROME 167 0.0087
73 UPPER GASTROINTESTINAL HAEMORRHAGE 147 0.0087
74 CHRONIC KIDNEY DISEASE 661 0.0087
75 VITAMIN D DEFICIENCY 84 0.0086
76 TRIGGER FINGER 35 0.0086
77 FLUSHING 866 0.0085
78 DYSMENORRHOEA 112 0.0084
79 TENDERNESS 88 0.0084
80 RESTLESS LEGS SYNDROME 153 0.0084
81 VENTRICULAR EXTRASYSTOLES 87 0.0084
82 INCREASED UPPER AIRWAY SECRETION 43 0.0084
83 ARTHROPOD BITE 62 0.0084
84 PERIPHERAL VASCULAR DISORDER 43 0.0083
85 BALANCE DISORDER 721 0.0083
86 SEASONAL ALLERGY 118 0.0083
87 ACTIVITIES OF DAILY LIVING IMPAIRED 165 0.0083
88 MULTIPLE ALLERGIES 65 0.0083
89 SKIN TIGHTNESS 39 0.0083
90 FAILURE TO THRIVE 43 0.0083
91 ANORECTAL DISCOMFORT 44 0.0083
92 AMMONIA INCREASED 42 0.0082
93 MENORRHAGIA 160 0.0081
94 THERAPY CHANGE 80 0.0081
95 MUSCLE ATROPHY 103 0.0081
96 BLOOD MAGNESIUM DECREASED 70 0.0081
97 IMPAIRED DRIVING ABILITY 92 0.0081
98 MICTURITION URGENCY 92 0.0080
99 EXERCISE TOLERANCE DECREASED 46 0.0080
100 ONYCHOMYCOSIS 35 0.0080
101 MUSCULOSKELETAL PAIN 417 0.0080
102 TEMPERATURE INTOLERANCE 82 0.0079
103 PIGMENTATION DISORDER 49 0.0079
104 NERVE INJURY 88 0.0079
105 SKIN WARM 46 0.0079
106 HAND FRACTURE 56 0.0079
107 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 43 0.0079
108 ATRIAL FLUTTER 63 0.0079
109 TENDONITIS 122 0.0079
110 HYPERLIPIDAEMIA 94 0.0079
111 BLOOD POTASSIUM DECREASED 236 0.0078
112 HYPERKERATOSIS 43 0.0078
113 FLUID OVERLOAD 113 0.0078
114 BLOOD IRON DECREASED 92 0.0077
115 ROSACEA 36 0.0077
116 BREAST TENDERNESS 58 0.0077
117 GINGIVAL SWELLING 34 0.0077
118 HOSPICE CARE 76 0.0077
119 NOCTURIA 93 0.0077
120 PRURITUS GENERALISED 165 0.0076
121 MUSCLE STRAIN 66 0.0076
122 SOMNAMBULISM 50 0.0076
123 SKIN ABRASION 36 0.0076
124 OSTEOPENIA 115 0.0076
125 BLOOD CHOLESTEROL ABNORMAL 35 0.0076
126 SINUSITIS 775 0.0076
127 FEELING JITTERY 144 0.0075
128 FLATULENCE 428 0.0075
129 BLOOD CHOLESTEROL INCREASED 351 0.0075
130 INTERNATIONAL NORMALISED RATIO INCREASED 214 0.0075
131 SQUAMOUS CELL CARCINOMA OF SKIN 45 0.0074
132 HYPERAESTHESIA 61 0.0074
133 WRIST FRACTURE 89 0.0074
134 MUSCLE TIGHTNESS 120 0.0074
135 RASH PAPULAR 166 0.0074
136 GASTROINTESTINAL HAEMORRHAGE 617 0.0074
137 SCAB 84 0.0074
138 HOT FLUSH 554 0.0073
139 HIATUS HERNIA 95 0.0073
140 SINUS DISORDER 145 0.0073
141 GINGIVAL PAIN 58 0.0073
142 GALLBLADDER DISORDER 130 0.0073
143 PHOTOPSIA 46 0.0073
144 DIABETIC NEUROPATHY 36 0.0073
145 CARDIAC FLUTTER 47 0.0073
146 MENSTRUAL DISORDER 60 0.0072
147 ARTERIOSCLEROSIS CORONARY ARTERY 48 0.0072
148 MITRAL VALVE INCOMPETENCE 82 0.0072
149 VAGINAL DISCHARGE 73 0.0072
150 TENDON RUPTURE 89 0.0072
151 BUNDLE BRANCH BLOCK RIGHT 33 0.0072
152 VARICOSE VEIN 37 0.0072
153 NERVE COMPRESSION 66 0.0071
154 RENAL FAILURE ACUTE 303 0.0071
155 CORONARY ARTERY DISEASE 216 0.0071
156 ACUTE RESPIRATORY FAILURE 137 0.0071
157 GASTROOESOPHAGEAL REFLUX DISEASE 573 0.0071
158 ENERGY INCREASED 42 0.0071
159 POOR QUALITY DRUG ADMINISTERED 46 0.0071
160 URINE OUTPUT DECREASED 62 0.0071
161 INTERNAL HAEMORRHAGE 81 0.0071
162 DRY MOUTH 574 0.0071
163 CARPAL TUNNEL SYNDROME 99 0.0071
164 SCREAMING 45 0.0071
165 BLOOD ALBUMIN DECREASED 56 0.0071
166 BLOOD URINE PRESENT 134 0.0071
167 HUMERUS FRACTURE 34 0.0070
168 BRUXISM 38 0.0070
169 PAROSMIA 53 0.0070
170 SCRATCH 74 0.0070
171 MUSCLE SPASTICITY 86 0.0070
172 PROCTALGIA 45 0.0070
173 MUSCULAR WEAKNESS 794 0.0070
174 LIGAMENT SPRAIN 69 0.0070
175 HAEMORRHOIDAL HAEMORRHAGE 34 0.0070
176 TOOTHACHE 126 0.0070
177 GROIN PAIN 61 0.0069
178 RENAL TUBULAR NECROSIS 68 0.0069
179 MUSCULOSKELETAL CHEST PAIN 107 0.0069
180 DYSPNOEA EXERTIONAL 260 0.0069
181 INJECTION SITE BRUISING 549 0.0069
182 MUSCLE SPASMS 1257 0.0068
183 CONTUSION 659 0.0068
184 HYPOVOLAEMIA 40 0.0068
185 HYPOAESTHESIA ORAL 103 0.0068
186 STENT PLACEMENT 55 0.0068
187 THERAPEUTIC RESPONSE UNEXPECTED 306 0.0068
188 POLLAKIURIA 284 0.0068
189 RENAL CYST 54 0.0068
190 BLOOD COUNT ABNORMAL 103 0.0068
191 CLOSTRIDIUM DIFFICILE COLITIS 72 0.0068
192 PANIC REACTION 49 0.0068
193 SCOLIOSIS 42 0.0068
194 SKIN ATROPHY 39 0.0068
195 SPINAL COMPRESSION FRACTURE 56 0.0068
196 MENTAL STATUS CHANGES 188 0.0068
197 INJECTION SITE HAEMORRHAGE 540 0.0068
198 BREAST PAIN 72 0.0067
199 CELLULITIS 340 0.0067
200 METRORRHAGIA 115 0.0067
201 CHROMATURIA 152 0.0067
202 FEELING HOT 412 0.0067
203 COMPRESSION FRACTURE 36 0.0067
204 UTERINE LEIOMYOMA 49 0.0067
205 BREAST MASS 45 0.0067
206 MYALGIA 1139 0.0067
207 BONE DISORDER 122 0.0067
208 PROTHROMBIN TIME PROLONGED 40 0.0067
209 HEART RATE IRREGULAR 151 0.0067
210 HYPERSOMNIA 191 0.0067
211 CLOSTRIDIUM DIFFICILE INFECTION 145 0.0066
212 VAGINAL HAEMORRHAGE 288 0.0066
213 PERIPHERAL COLDNESS 91 0.0066
214 VISUAL DISTURBANCE 38 0.0066
215 TINNITUS 304 0.0066
216 ANGINA UNSTABLE 43 0.0066
217 GAIT DISTURBANCE 1266 0.0066
218 HYPOPHAGIA 169 0.0066
219 DEEP VEIN THROMBOSIS 429 0.0066
220 GASTROENTERITIS VIRAL 119 0.0066
221 CATARACT OPERATION 39 0.0066
222 ERUCTATION 127 0.0066
223 BRONCHITIS 484 0.0065
224 INSOMNIA 1739 0.0065
225 DYSGEUSIA 485 0.0065
226 INCONTINENCE 69 0.0065
227 MOOD SWINGS 208 0.0065
228 NIGHT SWEATS 210 0.0065
229 ABASIA 161 0.0065
230 PANIC ATTACK 237 0.0065
231 IRON DEFICIENCY ANAEMIA 60 0.0065
232 AGEUSIA 162 0.0065
233 RECTAL HAEMORRHAGE 279 0.0065
234 BLOOD CALCIUM DECREASED 73 0.0065
235 STRESS FRACTURE 35 0.0065
236 BASAL CELL CARCINOMA 101 0.0065
237 BLOOD SODIUM DECREASED 122 0.0065
238 LABORATORY TEST ABNORMAL 191 0.0065
239 CONCUSSION 50 0.0065
240 RASH PRURITIC 350 0.0065
241 JOINT STIFFNESS 169 0.0064
242 TENDON DISORDER 42 0.0064
243 AORTIC ANEURYSM 49 0.0064
244 EAR DISCOMFORT 66 0.0064
245 PAIN IN JAW 182 0.0064
246 DEFAECATION URGENCY 45 0.0064
247 RIB FRACTURE 132 0.0064
248 POST-TRAUMATIC STRESS DISORDER 43 0.0064
249 RASH GENERALISED 166 0.0064
250 NASAL CONGESTION 375 0.0064
251 PARAESTHESIA 1003 0.0064
252 FALL 2121 0.0064
253 FAECES DISCOLOURED 138 0.0064
254 LYMPHOEDEMA 44 0.0064
255 NECK PAIN 355 0.0063
256 INTERVERTEBRAL DISC PROTRUSION 138 0.0063
257 VITREOUS FLOATERS 62 0.0063
258 OSTEOARTHRITIS 267 0.0063
259 MUSCLE DISORDER 51 0.0063
260 TOOTH DISORDER 140 0.0063
261 ANOREXIA 81 0.0063
262 MENSTRUATION DELAYED 68 0.0063
263 HYPOAESTHESIA 939 0.0063
264 BOWEL MOVEMENT IRREGULARITY 48 0.0063
265 DYSSTASIA 183 0.0063
266 TOOTH FRACTURE 69 0.0063
267 DECUBITUS ULCER 51 0.0063
268 FREQUENT BOWEL MOVEMENTS 169 0.0062
269 WRONG TECHNIQUE IN DRUG USAGE PROCESS 227 0.0062
270 ONYCHOCLASIS 43 0.0062
271 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 444 0.0062
272 JOINT INJURY 133 0.0062
273 NASAL DRYNESS 39 0.0062
274 HAIR TEXTURE ABNORMAL 83 0.0062
275 MUSCLE TWITCHING 143 0.0062
276 FEELING DRUNK 46 0.0062
277 TOOTH ABSCESS 63 0.0062
278 GOUT 111 0.0062
279 RHINORRHOEA 399 0.0062
280 BACK PAIN 1434 0.0062
281 NAIL DISORDER 54 0.0062
282 DYSPEPSIA 606 0.0062
283 RED BLOOD CELL COUNT DECREASED 176 0.0061
284 BACK DISORDER 100 0.0061
285 SCIATICA 98 0.0061
286 DENTAL CARIES 68 0.0061
287 DRUG EFFECT DECREASED 331 0.0061
288 TOOTH INFECTION 81 0.0061
289 BLADDER DISORDER 61 0.0061
290 CONSTIPATION 1339 0.0061
291 PRODUCT DOSE OMISSION 400 0.0061
292 ASTHENIA 2302 0.0061
293 RASH MACULAR 214 0.0061
294 ORAL PAIN 137 0.0061
295 POLYP 40 0.0061
296 GLUCOSE TOLERANCE IMPAIRED 36 0.0061
297 NERVOUSNESS 318 0.0061
298 FLANK PAIN 57 0.0061
299 BACK INJURY 66 0.0061
300 STAPHYLOCOCCAL INFECTION 200 0.0061
301 LARGE INTESTINE POLYP 42 0.0061
302 FURUNCLE 48 0.0061
303 ATRIAL FIBRILLATION 589 0.0060
304 ABNORMAL DREAMS 167 0.0060
305 PRESYNCOPE 147 0.0060
306 RESPIRATORY TRACT CONGESTION 96 0.0060
307 UNEVALUABLE EVENT 457 0.0060
308 OROPHARYNGEAL PAIN 559 0.0060
309 UPPER RESPIRATORY TRACT INFECTION 279 0.0060
310 IMPAIRED WORK ABILITY 129 0.0060
311 FEELING ABNORMAL 1445 0.0060
312 MACULAR DEGENERATION 72 0.0060
313 BURNING SENSATION 422 0.0060
314 ABNORMAL LOSS OF WEIGHT 41 0.0060
315 NEUROPATHY PERIPHERAL 572 0.0060
316 OEDEMA PERIPHERAL 733 0.0060
317 VIRAL INFECTION 200 0.0060
318 DRY THROAT 61 0.0060
319 MALNUTRITION 67 0.0060
320 PAIN OF SKIN 161 0.0060
321 BLOOD UREA INCREASED 100 0.0060
322 CRYING 217 0.0060
323 HICCUPS 49 0.0060
324 DRUG DOSE OMISSION 986 0.0060
325 NEURALGIA 145 0.0060
326 OSTEOPOROSIS 245 0.0060
327 DEPRESSION 1351 0.0059
328 DEHYDRATION 792 0.0059
329 HEAD DISCOMFORT 105 0.0059
330 ABDOMINAL DISTENSION 619 0.0059
331 NASAL DISCOMFORT 47 0.0059
332 PELVIC FRACTURE 46 0.0059
333 PULMONARY HYPERTENSION 123 0.0059
334 DYSURIA 217 0.0059
335 DIVERTICULITIS 163 0.0059
336 CYST 73 0.0059
337 HYDRONEPHROSIS 44 0.0059
338 LETHARGY 338 0.0059
339 INCOHERENT 38 0.0059
340 EAR PAIN 114 0.0059
341 DISTURBANCE IN ATTENTION 316 0.0059
342 PHARYNGEAL OEDEMA 90 0.0058
343 PHOTOPHOBIA 110 0.0058
344 DYSPHONIA 342 0.0058
345 WEIGHT DECREASED 1631 0.0058
346 SQUAMOUS CELL CARCINOMA 55 0.0058
347 INJECTION SITE PRURITUS 391 0.0058
348 CHILLS 684 0.0058
349 TRANSFUSION 61 0.0058
350 CARDIAC FAILURE CONGESTIVE 467 0.0058
351 MUSCULOSKELETAL DISCOMFORT 100 0.0058
352 URINARY INCONTINENCE 172 0.0058
353 DIZZINESS 2894 0.0058
354 SLUGGISHNESS 59 0.0058
355 TROPONIN INCREASED 44 0.0058
356 SCAR 99 0.0058
357 FLUID RETENTION 294 0.0058
358 ORAL CANDIDIASIS 76 0.0058
359 BURSITIS 70 0.0058
360 FATIGUE 4485 0.0058
361 POOR QUALITY SLEEP 124 0.0058
362 BLOOD THYROID STIMULATING HORMONE INCREASED 53 0.0058
363 ANKLE FRACTURE 89 0.0057
364 FOOT FRACTURE 109 0.0057
365 HAEMORRHOIDS 112 0.0057
366 ELECTROCARDIOGRAM ABNORMAL 45 0.0057
367 CHOLELITHIASIS 188 0.0057
368 COLD SWEAT 101 0.0057
369 PALPITATIONS 671 0.0057
370 INJECTION SITE INDURATION 74 0.0057
371 CARDIAC PACEMAKER INSERTION 34 0.0057
372 PAIN IN EXTREMITY 1675 0.0057
373 EPISTAXIS 425 0.0057
374 FEELING COLD 158 0.0057
375 DIARRHOEA HAEMORRHAGIC 53 0.0057
376 HIP FRACTURE 182 0.0057
377 THIRST 101 0.0056
378 CYSTITIS 180 0.0056
379 SUNBURN 42 0.0056
380 ACNE 427 0.0056
381 ARTHRITIS 443 0.0056
382 TRANSIENT ISCHAEMIC ATTACK 190 0.0056
383 HAEMOGLOBIN DECREASED 577 0.0056
384 CARDIOMEGALY 69 0.0056
385 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 292 0.0056
386 RENAL FAILURE 743 0.0056
387 PULMONARY MASS 83 0.0056
388 ERECTILE DYSFUNCTION 143 0.0056
389 URINARY TRACT INFECTION 949 0.0056
390 GASTROINTESTINAL PAIN 61 0.0055
391 FEAR 149 0.0055
392 SUPRAVENTRICULAR TACHYCARDIA 53 0.0055
393 RETCHING 118 0.0055
394 HEAD INJURY 175 0.0055
395 INJECTION SITE ERYTHEMA 684 0.0055
396 PHOTOSENSITIVITY REACTION 91 0.0055
397 SECRETION DISCHARGE 69 0.0055
398 ABNORMAL FAECES 45 0.0055
399 CHEST PAIN 1017 0.0055
400 OBSESSIVE-COMPULSIVE DISORDER 44 0.0055
401 ANGER 185 0.0055
402 ENTERITIS 35 0.0055
403 INFLUENZA LIKE ILLNESS 450 0.0055
404 LIMB DISCOMFORT 169 0.0055
405 THROAT IRRITATION 244 0.0054
406 SKIN INFECTION 61 0.0054
407 CARDIAC MURMUR 47 0.0054
408 INJECTION SITE EXTRAVASATION 67 0.0054
409 UPPER LIMB FRACTURE 108 0.0054
410 CHEST DISCOMFORT 555 0.0054
411 DIARRHOEA 3488 0.0054
412 HEART RATE INCREASED 535 0.0054
413 MUSCULOSKELETAL STIFFNESS 473 0.0054
414 ORAL DISCOMFORT 75 0.0054
415 ECCHYMOSIS 37 0.0054
416 RENAL INJURY 160 0.0054
417 TREMOR 892 0.0054
418 HYPOKINESIA 78 0.0054
419 RESPIRATION ABNORMAL 37 0.0054
420 THERAPEUTIC RESPONSE CHANGED 34 0.0054
421 EMPHYSEMA 54 0.0053
422 MEMORY IMPAIRMENT 735 0.0053
423 HAIR GROWTH ABNORMAL 37 0.0053
424 HYPERCALCAEMIA 66 0.0053
425 CHOLECYSTECTOMY 61 0.0053
426 FORMICATION 37 0.0053
427 ANXIETY 1513 0.0053
428 GASTRIC ULCER 101 0.0053
429 DRUG EFFECT INCOMPLETE 193 0.0053
430 COORDINATION ABNORMAL 74 0.0053
431 OSTEOMYELITIS 96 0.0053
432 MIGRAINE 504 0.0053
433 PLEURAL EFFUSION 320 0.0053
434 HYPOXIA 185 0.0052
435 BEDRIDDEN 69 0.0052
436 BONE PAIN 307 0.0052
437 SUBDURAL HAEMATOMA 75 0.0052
438 ABDOMINAL PAIN 1218 0.0052
439 PARANOIA 90 0.0052
440 INJECTION SITE PAIN 1601 0.0052
441 APATHY 76 0.0052
442 RHINITIS 42 0.0052
443 INJECTION SITE DISCOLOURATION 65 0.0052
444 INJECTION SITE WARMTH 107 0.0052
445 MOTOR DYSFUNCTION 53 0.0052
446 ANGINA PECTORIS 149 0.0052
447 MENTAL IMPAIRMENT 126 0.0052
448 INCORRECT DRUG ADMINISTRATION DURATION 146 0.0052
449 EAR INFECTION 138 0.0052
450 POSTOPERATIVE WOUND INFECTION 35 0.0052
451 ANOSMIA 75 0.0052
452 ARTHRALGIA 2153 0.0052
453 BLOOD POTASSIUM INCREASED 84 0.0052
454 DERMATITIS CONTACT 59 0.0052
455 EYE SWELLING 192 0.0052
456 HALLUCINATION, AUDITORY 82 0.0052
457 DYSGRAPHIA 34 0.0052
458 FUNGAL INFECTION 172 0.0052
459 DECREASED APPETITE 1197 0.0051
460 RASH ERYTHEMATOUS 246 0.0051
461 NEPHROLITHIASIS 236 0.0051
462 PARAESTHESIA ORAL 74 0.0051
463 SNEEZING 115 0.0051
464 BLOOD PRESSURE INCREASED 783 0.0051
465 HYPERHIDROSIS 659 0.0051
466 LOSS OF LIBIDO 46 0.0051
467 ORTHOSTATIC HYPOTENSION 89 0.0051
468 ABDOMINAL PAIN UPPER 1051 0.0051
469 SENSATION OF FOREIGN BODY 43 0.0051
470 ARTERIOSCLEROSIS 48 0.0051
471 VISION BLURRED 700 0.0051
472 MYOPATHY 44 0.0051
473 PERIPHERAL SWELLING 784 0.0051
474 DELUSION 79 0.0051
475 PULMONARY EMBOLISM 483 0.0051
476 PROSTATIC SPECIFIC ANTIGEN INCREASED 70 0.0051
477 CONFUSIONAL STATE 821 0.0051
478 JOINT EFFUSION 35 0.0051
479 QUALITY OF LIFE DECREASED 68 0.0051
480 CATARACT 301 0.0050
481 POST PROCEDURAL COMPLICATION 97 0.0050
482 THINKING ABNORMAL 94 0.0050
483 POST PROCEDURAL INFECTION 41 0.0050
484 IMPAIRED HEALING 165 0.0050
485 PLASMA CELL MYELOMA 196 0.0050
486 AMNESIA 326 0.0050
487 PULMONARY CONGESTION 66 0.0050
488 RENAL PAIN 53 0.0050
489 NAUSEA 3955 0.0050
490 LUNG INFILTRATION 44 0.0050
491 INJECTION SITE MASS 184 0.0050
492 TONGUE DISORDER 36 0.0050
493 MOBILITY DECREASED 357 0.0050
494 HEADACHE 3113 0.0050
495 LOCALISED INFECTION 120 0.0050
496 ARTERIAL OCCLUSIVE DISEASE 39 0.0050
497 LIVER FUNCTION TEST ABNORMAL 144 0.0049
498 APHONIA 69 0.0049
499 SKIN DISCOLOURATION 227 0.0049
500 CARDIOMYOPATHY 73 0.0049
501 THERMAL BURN 35 0.0049
502 DRUG ADMINISTERED AT INAPPROPRIATE SITE 52 0.0049
503 SKIN BURNING SENSATION 353 0.0049
504 SENSORY DISTURBANCE 79 0.0049
505 NIGHTMARE 170 0.0049
506 COUGH 1375 0.0049
507 WHITE BLOOD CELL COUNT DECREASED 531 0.0049
508 INJECTION SITE URTICARIA 120 0.0049
509 HEPATIC STEATOSIS 91 0.0049
510 HALLUCINATION, VISUAL 103 0.0049
511 FOOT DEFORMITY 54 0.0049
512 EYE HAEMORRHAGE 65 0.0049
513 EYE INFECTION 55 0.0049
514 DISORIENTATION 193 0.0049
515 EXTRASYSTOLES 34 0.0049
516 HAEMATOCHEZIA 268 0.0049
517 KIDNEY INFECTION 95 0.0048
518 ASPIRATION 53 0.0048
519 NODULE 63 0.0048
520 SKIN EXFOLIATION 407 0.0048
521 VERTIGO 294 0.0048
522 HAIR COLOUR CHANGES 60 0.0048
523 NEPHROPATHY 45 0.0048
524 ANAEMIA 919 0.0048
525 APPLICATION SITE PAIN 106 0.0048
526 LIP SWELLING 160 0.0048
527 HAEMOPTYSIS 134 0.0048
528 FISTULA 54 0.0048
529 MOOD ALTERED 131 0.0048
530 SPINAL FRACTURE 96 0.0048
531 DRY EYE 239 0.0048
532 CHOLECYSTITIS 57 0.0048
533 STOMATITIS 290 0.0048
534 DERMATITIS 100 0.0048
535 ERYTHEMA 981 0.0048
536 DRY SKIN 636 0.0048
537 JOINT SWELLING 575 0.0048
538 ASPARTATE AMINOTRANSFERASE INCREASED 253 0.0048
539 SWELLING FACE 310 0.0048
540 OESOPHAGITIS 52 0.0048
541 ECONOMIC PROBLEM 72 0.0047
542 ESCHERICHIA INFECTION 39 0.0047
543 NASOPHARYNGITIS 873 0.0047
544 PRODUCTIVE COUGH 226 0.0047
545 FIBROMYALGIA 115 0.0047
546 ATAXIA 56 0.0047
547 COGNITIVE DISORDER 220 0.0047
548 SKIN FISSURES 92 0.0047
549 EYE PAIN 265 0.0047
550 BIPOLAR DISORDER 51 0.0047
551 COELIAC DISEASE 46 0.0047
552 RETINAL DETACHMENT 43 0.0047
553 HAEMATOMA 121 0.0047
554 FOOD ALLERGY 36 0.0047
555 OEDEMA 252 0.0046
556 SKIN ULCER 120 0.0046
557 LUNG INFECTION 72 0.0046
558 BACTERAEMIA 55 0.0046
559 LACRIMATION INCREASED 140 0.0046
560 SKIN IRRITATION 212 0.0046
561 ABDOMINAL DISCOMFORT 776 0.0046
562 PHARYNGITIS STREPTOCOCCAL 50 0.0046
563 APPLICATION SITE ERYTHEMA 121 0.0046
564 DYSPNOEA 2612 0.0046
565 BACTERIAL INFECTION 86 0.0046
566 BLINDNESS UNILATERAL 65 0.0046
567 SPEECH DISORDER 241 0.0046
568 SENSORY LOSS 37 0.0046
569 GASTROINTESTINAL INFLAMMATION 36 0.0046
570 HUNGER 64 0.0046
571 BLOOD ALKALINE PHOSPHATASE INCREASED 114 0.0046
572 MADAROSIS 53 0.0046
573 ANAL INCONTINENCE 41 0.0046
574 GLOSSODYNIA 102 0.0046
575 JOINT RANGE OF MOTION DECREASED 61 0.0045
576 DIPLOPIA 118 0.0045
577 BLISTER 255 0.0045
578 BLOOD GLUCOSE DECREASED 218 0.0045
579 ALOPECIA 890 0.0045
580 HAEMODIALYSIS 38 0.0045
581 SPLENOMEGALY 53 0.0045
582 MULTIPLE SCLEROSIS RELAPSE 310 0.0045
583 PNEUMONIA 1459 0.0045
584 SKIN CANCER 97 0.0045
585 APHASIA 136 0.0045
586 ACUTE KIDNEY INJURY 689 0.0045
587 WEIGHT INCREASED 1003 0.0045
588 HYPOTHYROIDISM 143 0.0045
589 ACUTE MYOCARDIAL INFARCTION 132 0.0045
590 THROAT TIGHTNESS 121 0.0045
591 HERPES ZOSTER 257 0.0045
592 ABDOMINAL PAIN LOWER 113 0.0045
593 INJURY 314 0.0045
594 MASS 62 0.0044
595 LYMPHADENOPATHY 157 0.0044
596 GASTRIC DISORDER 152 0.0044
597 NO THERAPEUTIC RESPONSE 54 0.0044
598 SKIN HYPERPIGMENTATION 38 0.0044
599 HEPATIC ENZYME INCREASED 301 0.0044
600 SLEEP DISORDER 311 0.0044
601 OVARIAN CYST 44 0.0044
602 SKIN DISORDER 146 0.0044
603 IRRITABILITY 263 0.0044
604 ARTHROPATHY 243 0.0044
605 MULTIPLE SCLEROSIS 209 0.0044
606 HAIR DISORDER 36 0.0044
607 PERICARDIAL EFFUSION 101 0.0044
608 HAEMORRHAGIC STROKE 34 0.0043
609 PLATELET COUNT DECREASED 464 0.0043
610 COLITIS 165 0.0043
611 GASTROINTESTINAL INFECTION 39 0.0043
612 INFLUENZA 485 0.0043
613 PULMONARY ARTERIAL HYPERTENSION 63 0.0043
614 URINARY RETENTION 145 0.0043
615 UROSEPSIS 40 0.0043
616 IMMUNE SYSTEM DISORDER 57 0.0043
617 SKIN LACERATION 47 0.0043
618 HAEMATURIA 148 0.0043
619 EJECTION FRACTION DECREASED 67 0.0043
620 DYSARTHRIA 162 0.0043
621 URTICARIA 720 0.0043
622 PRODUCT ODOUR ABNORMAL 45 0.0043
623 EATING DISORDER 91 0.0043
624 HEART RATE DECREASED 150 0.0043
625 SOMNOLENCE 860 0.0043
626 DRUG ADMINISTRATION ERROR 131 0.0043
627 GLAUCOMA 82 0.0043
628 BLOOD BILIRUBIN INCREASED 115 0.0043
629 JOINT DISLOCATION 45 0.0043
630 RASH 1855 0.0043
631 SKIN HAEMORRHAGE 63 0.0042
632 APNOEA 33 0.0042
633 BODY TEMPERATURE INCREASED 86 0.0042
634 VISUAL ACUITY REDUCED 140 0.0042
635 POST PROCEDURAL HAEMORRHAGE 49 0.0042
636 WEIGHT FLUCTUATION 44 0.0042
637 INJECTION SITE RASH 129 0.0042
638 MOVEMENT DISORDER 135 0.0042
639 BLOOD TEST ABNORMAL 59 0.0042
640 PERSONALITY CHANGE 39 0.0042
641 HALLUCINATION 316 0.0042
642 HEMIPARESIS 71 0.0042
643 MENSTRUATION IRREGULAR 112 0.0042
644 DEPRESSED MOOD 221 0.0042
645 GASTRITIS 110 0.0042
646 SYNCOPE 417 0.0042
647 PSORIASIS 543 0.0042
648 THYROID DISORDER 64 0.0041
649 INJECTION SITE SWELLING 318 0.0041
650 PRURITUS 1593 0.0041
651 PRODUCT QUALITY ISSUE 563 0.0041
652 LEUKOCYTOSIS 75 0.0041
653 WHITE BLOOD CELL COUNT INCREASED 159 0.0041
654 TYPE 2 DIABETES MELLITUS 139 0.0041
655 BLOOD PRESSURE ABNORMAL 82 0.0041
656 PANCREATITIS 217 0.0041
657 MALIGNANT MELANOMA 55 0.0041
658 IRRITABLE BOWEL SYNDROME 88 0.0041
659 THROMBOSIS 329 0.0041
660 PULMONARY OEDEMA 183 0.0041
661 HEPATIC ENCEPHALOPATHY 38 0.0041
662 DYSPHAGIA 386 0.0041
663 SWOLLEN TONGUE 127 0.0041
664 BLOOD PRESSURE DECREASED 270 0.0041
665 VENTRICULAR TACHYCARDIA 67 0.0041
666 ALANINE AMINOTRANSFERASE INCREASED 249 0.0041
667 WOUND 113 0.0040
668 PYELONEPHRITIS 35 0.0040
669 UNRESPONSIVE TO STIMULI 104 0.0040
670 PAIN 2469 0.0040
671 PSORIATIC ARTHROPATHY 163 0.0040
672 MANIA 66 0.0040
673 APPLICATION SITE PRURITUS 91 0.0040
674 PHARMACEUTICAL PRODUCT COMPLAINT 104 0.0040
675 BLOOD PRESSURE FLUCTUATION 96 0.0040
676 RESTLESSNESS 146 0.0040
677 CARDIAC OPERATION 34 0.0040
678 GINGIVAL BLEEDING 54 0.0040
679 ENCEPHALOPATHY 97 0.0039
680 TUBULOINTERSTITIAL NEPHRITIS 74 0.0039
681 SUICIDAL IDEATION 361 0.0039
682 RESPIRATORY RATE INCREASED 35 0.0039
683 HYPERCHOLESTEROLAEMIA 38 0.0039
684 SPINAL PAIN 46 0.0039
685 HYPERTENSION 831 0.0039
686 VOMITING 1843 0.0039
687 SKIN SWELLING 34 0.0039
688 INJECTION SITE REACTION 269 0.0039
689 KNEE ARTHROPLASTY 82 0.0039
690 DECREASED ACTIVITY 42 0.0039
691 MULTI-ORGAN FAILURE 67 0.0039
692 PANCREATITIS ACUTE 87 0.0039
693 GRIP STRENGTH DECREASED 34 0.0039
694 ANHEDONIA 101 0.0038
695 RHABDOMYOLYSIS 160 0.0038
696 BLOOD GLUCOSE FLUCTUATION 42 0.0038
697 DEMENTIA 107 0.0038
698 SINUS BRADYCARDIA 37 0.0038
699 SWELLING 358 0.0038
700 SEPSIS 426 0.0038
701 ASCITES 112 0.0038
702 GENERALISED OEDEMA 47 0.0038
703 INTESTINAL OBSTRUCTION 143 0.0038
704 PHARYNGITIS 47 0.0038
705 AGITATION 278 0.0038
706 HYPERSENSITIVITY 702 0.0038
707 ULCER 60 0.0038
708 ABSCESS 60 0.0038
709 LIMB INJURY 102 0.0038
710 SKIN LESION 103 0.0038
711 BLOOD CREATININE INCREASED 245 0.0037
712 CHOKING 73 0.0037
713 PETECHIAE 39 0.0037
714 INFUSION SITE PAIN 48 0.0037
715 HERNIA 72 0.0037
716 WITHDRAWAL SYNDROME 156 0.0037
717 FEMUR FRACTURE 115 0.0037
718 CENTRAL NERVOUS SYSTEM LESION 51 0.0037
719 EYE DISORDER 122 0.0037
720 PYREXIA 1283 0.0037
721 HYPOTENSION 743 0.0037
722 EYELID OEDEMA 43 0.0037
723 PRODUCT TASTE ABNORMAL 50 0.0037
724 SPUTUM DISCOLOURED 35 0.0037
725 BLOOD GLUCOSE INCREASED 694 0.0037
726 PSYCHOMOTOR HYPERACTIVITY 61 0.0037
727 HEPATOMEGALY 36 0.0037
728 ADVERSE DRUG REACTION 329 0.0037
729 BODY TEMPERATURE DECREASED 36 0.0037
730 HIP ARTHROPLASTY 56 0.0037
731 INTENTIONAL PRODUCT MISUSE 320 0.0037
732 COLITIS ULCERATIVE 163 0.0036
733 LOWER LIMB FRACTURE 70 0.0036
734 DEAFNESS 95 0.0036
735 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 174 0.0036
736 GAIT INABILITY 121 0.0036
737 TOOTH EXTRACTION 45 0.0036
738 INCREASED APPETITE 69 0.0036
739 ROAD TRAFFIC ACCIDENT 151 0.0036
740 CARDIAC DISORDER 337 0.0036
741 DYSKINESIA 146 0.0036
742 RENAL DISORDER 167 0.0036
743 BLOOD CREATINE PHOSPHOKINASE INCREASED 103 0.0036
744 INCORRECT PRODUCT STORAGE 47 0.0036
745 WOUND INFECTION 39 0.0036
746 LOSS OF CONSCIOUSNESS 456 0.0036
747 ABNORMAL BEHAVIOUR 141 0.0036
748 DIALYSIS 50 0.0035
749 EYE PRURITUS 118 0.0035
750 OXYGEN SATURATION DECREASED 197 0.0035
751 MYOCARDIAL INFARCTION 610 0.0035
752 APPLICATION SITE RASH 48 0.0035
753 HYPERGLYCAEMIA 127 0.0035
754 OCULAR DISCOMFORT 39 0.0035
755 VISUAL IMPAIRMENT 429 0.0035
756 WHEEZING 205 0.0035
757 SINUS TACHYCARDIA 49 0.0034
758 INJECTION SITE HAEMATOMA 50 0.0034
759 COMPLICATION ASSOCIATED WITH DEVICE 50 0.0034
760 EMOTIONAL DISORDER 106 0.0034
761 CANDIDA INFECTION 58 0.0034
762 RED BLOOD CELL SEDIMENTATION RATE INCREASED 38 0.0034
763 HYPOKALAEMIA 158 0.0034
764 CONVULSION 195 0.0034
765 DRUG DISPENSING ERROR 52 0.0034
766 INTESTINAL PERFORATION 38 0.0034
767 HYPOMAGNESAEMIA 47 0.0034
768 MALAISE 1479 0.0034
769 GLYCOSYLATED HAEMOGLOBIN INCREASED 85 0.0034
770 MELAENA 74 0.0034
771 DISCOMFORT 205 0.0034
772 TASTE DISORDER 68 0.0033
773 JAUNDICE 90 0.0033
774 DEVICE DISLOCATION 145 0.0033
775 HAEMATEMESIS 84 0.0033
776 CONDITION AGGRAVATED 1007 0.0033
777 FEEDING DISORDER 67 0.0033
778 PULMONARY THROMBOSIS 36 0.0033
779 PLATELET COUNT INCREASED 43 0.0033
780 OCULAR HYPERAEMIA 156 0.0033
781 DEVICE MALFUNCTION 230 0.0033
782 SKIN REACTION 46 0.0033
783 OBESITY 52 0.0033
784 RESPIRATORY TRACT INFECTION 85 0.0033
785 AGGRESSION 163 0.0033
786 DEVICE RELATED INFECTION 50 0.0032
787 PROCEDURAL PAIN 90 0.0032
788 CEREBROVASCULAR ACCIDENT 549 0.0032
789 PALLOR 88 0.0032
790 EYE IRRITATION 186 0.0032
791 IMPAIRED GASTRIC EMPTYING 44 0.0032
792 GASTROENTERITIS 47 0.0032
793 DISEASE PROGRESSION 380 0.0032
794 MUSCULOSKELETAL DISORDER 61 0.0032
795 RHEUMATOID ARTHRITIS 363 0.0032
796 ACCIDENT 38 0.0032
797 ORAL HERPES 62 0.0032
798 VENTRICULAR FIBRILLATION 35 0.0031
799 INFLAMMATION 162 0.0031
800 APPLICATION SITE IRRITATION 39 0.0031
801 HYPONATRAEMIA 176 0.0031
802 RESPIRATORY FAILURE 227 0.0031
803 TACHYCARDIA 275 0.0031
804 MYOCARDIAL ISCHAEMIA 35 0.0031
805 LIVER FUNCTION TEST INCREASED 66 0.0031
806 CEREBRAL HAEMORRHAGE 110 0.0031
807 HYPOACUSIS 132 0.0031
808 DIABETES MELLITUS 233 0.0031
809 PNEUMOTHORAX 48 0.0030
810 BLOOD PRESSURE SYSTOLIC INCREASED 59 0.0030
811 HAEMORRHAGE 316 0.0030
812 ARRHYTHMIA 143 0.0030
813 ELECTROLYTE IMBALANCE 35 0.0030
814 GLOMERULAR FILTRATION RATE DECREASED 37 0.0030
815 PARALYSIS 43 0.0030
816 SEXUAL DYSFUNCTION 35 0.0030
817 HEPATIC CIRRHOSIS 56 0.0030
818 PANCYTOPENIA 166 0.0030
819 GASTROINTESTINAL DISORDER 266 0.0030
820 INTENTIONAL DRUG MISUSE 62 0.0030
821 MENTAL DISORDER 129 0.0030
822 MYDRIASIS 38 0.0030
823 UNDERDOSE 216 0.0030
824 DRUG INEFFECTIVE 3893 0.0030
825 DEVICE ISSUE 264 0.0029
826 DERMATITIS ALLERGIC 37 0.0029
827 PNEUMONIA ASPIRATION 73 0.0029
828 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 68 0.0029
829 ILEUS 36 0.0029
830 MEDICATION ERROR 161 0.0029
831 NEUTROPHIL COUNT DECREASED 118 0.0029
832 INFECTION 419 0.0029
833 COLON CANCER 43 0.0029
834 HYPERKALAEMIA 101 0.0029
835 HAEMORRHAGE INTRACRANIAL 43 0.0029
836 PNEUMONITIS 78 0.0029
837 DRUG TOXICITY 39 0.0029
838 DRUG PRESCRIBING ERROR 55 0.0029
839 MULTIPLE FRACTURES 47 0.0029
840 MOUTH ULCERATION 60 0.0028
841 LYMPHOMA 44 0.0028
842 RESPIRATORY DISORDER 85 0.0028
843 PRODUCT PHYSICAL ISSUE 57 0.0028
844 DRUG INTERACTION 448 0.0028
845 HYPOGLYCAEMIA 136 0.0028
846 BRADYCARDIA 148 0.0028
847 METASTASES TO LIVER 49 0.0028
848 HYPERTHYROIDISM 40 0.0028
849 TREATMENT NONCOMPLIANCE 151 0.0028
850 SEIZURE 318 0.0028
851 IMMUNODEFICIENCY 41 0.0027
852 INJECTION SITE IRRITATION 35 0.0027
853 INTRAOCULAR PRESSURE INCREASED 35 0.0027
854 DEVICE EXPULSION 177 0.0027
855 METABOLIC ACIDOSIS 87 0.0027
856 PRESCRIBED OVERDOSE 52 0.0027
857 LIVER DISORDER 119 0.0027
858 PULMONARY FIBROSIS 51 0.0027
859 DIABETES MELLITUS INADEQUATE CONTROL 47 0.0027
860 THROMBOCYTOPENIA 295 0.0026
861 SURGERY 154 0.0026
862 METASTASES TO BONE 43 0.0026
863 LUNG DISORDER 128 0.0026
864 PRESCRIBED UNDERDOSE 52 0.0026
865 ASTHMA 293 0.0026
866 INCORRECT DOSE ADMINISTERED 591 0.0026
867 SEPTIC SHOCK 110 0.0025
868 RENAL IMPAIRMENT 212 0.0025
869 PREMATURE DELIVERY 40 0.0025
870 CONJUNCTIVITIS 46 0.0025
871 PSYCHOTIC DISORDER 73 0.0025
872 EXPIRED PRODUCT ADMINISTERED 82 0.0025
873 BONE LOSS 37 0.0025
874 PRODUCT USE ISSUE 461 0.0025
875 EXTRA DOSE ADMINISTERED 99 0.0024
876 BLOOD GLUCOSE ABNORMAL 45 0.0024
877 DEVICE FAILURE 37 0.0024
878 INSURANCE ISSUE 37 0.0024
879 PRODUCT USE COMPLAINT 38 0.0024
880 PREGNANCY 48 0.0024
881 RESPIRATORY DISTRESS 66 0.0024
882 RESPIRATORY ARREST 65 0.0024
883 LYMPHOCYTE COUNT DECREASED 41 0.0023
884 BRONCHOSPASM 33 0.0023
885 ACUTE MYELOID LEUKAEMIA 36 0.0023
886 THERAPY INTERRUPTED 165 0.0023
887 INTENTIONAL PRODUCT USE ISSUE 199 0.0023
888 HOSPITALISATION 349 0.0023
889 DELIRIUM 78 0.0022
890 GENERALISED TONIC-CLONIC SEIZURE 37 0.0022
891 CYANOSIS 35 0.0022
892 AMENORRHOEA 39 0.0022
893 SEDATION 58 0.0022
894 BONE DENSITY DECREASED 69 0.0022
895 DEPRESSED LEVEL OF CONSCIOUSNESS 87 0.0022
896 THERAPEUTIC RESPONSE DECREASED 133 0.0022
897 FEBRILE NEUTROPENIA 143 0.0022
898 CARDIO-RESPIRATORY ARREST 90 0.0022
899 DRUG INTOLERANCE 206 0.0021
900 HEPATIC FAILURE 64 0.0021
901 ILL-DEFINED DISORDER 128 0.0021
902 PROTEINURIA 40 0.0021
903 ABORTION SPONTANEOUS 84 0.0021
904 CARDIAC FAILURE 168 0.0021
905 NEUTROPENIA 284 0.0021
906 CARDIAC ARREST 172 0.0021
907 BLOOD LACTATE DEHYDROGENASE INCREASED 33 0.0021
908 SEROTONIN SYNDROME 40 0.0021
909 FACE OEDEMA 35 0.0021
910 TOOTH LOSS 43 0.0021
911 HEPATITIS 53 0.0021
912 STEVENS-JOHNSON SYNDROME 46 0.0021
913 THERAPY NON-RESPONDER 93 0.0021
914 NERVOUS SYSTEM DISORDER 64 0.0020
915 MALIGNANT NEOPLASM PROGRESSION 209 0.0020
916 DRUG WITHDRAWAL SYNDROME 177 0.0020
917 ANAPHYLACTIC REACTION 111 0.0020
918 DIABETIC KETOACIDOSIS 48 0.0020
919 OSTEONECROSIS OF JAW 49 0.0020
920 NEEDLE ISSUE 57 0.0020
921 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 107 0.0019
922 EMOTIONAL DISTRESS 233 0.0019
923 EXPOSURE DURING PREGNANCY 119 0.0019
924 ADVERSE EVENT 176 0.0019
925 BLINDNESS 77 0.0019
926 MUCOSAL INFLAMMATION 49 0.0019
927 DISABILITY 37 0.0019
928 ECZEMA 97 0.0019
929 RASH MACULO-PAPULAR 41 0.0018
930 INCORRECT DOSE ADMINISTERED BY DEVICE 48 0.0018
931 INCORRECT ROUTE OF DRUG ADMINISTRATION 65 0.0018
932 ELECTROCARDIOGRAM QT PROLONGED 65 0.0018
933 INTENTIONAL DOSE OMISSION 51 0.0018
934 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 60 0.0018
935 INJURY ASSOCIATED WITH DEVICE 36 0.0018
936 TRANSAMINASES INCREASED 39 0.0018
937 ACCIDENTAL OVERDOSE 64 0.0017
938 DISEASE RECURRENCE 83 0.0017
939 PERITONITIS 36 0.0017
940 TARDIVE DYSKINESIA 49 0.0017
941 PRODUCT ADHESION ISSUE 62 0.0017
942 CARDIOVASCULAR DISORDER 44 0.0017
943 GENERAL PHYSICAL HEALTH DETERIORATION 200 0.0017
944 DRUG-INDUCED LIVER INJURY 54 0.0017
945 HEPATOTOXICITY 38 0.0017
946 OFF LABEL USE 1479 0.0017
947 ANGIOEDEMA 74 0.0017
948 LEUKOPENIA 83 0.0017
949 INFUSION RELATED REACTION 107 0.0016
950 SHOCK 37 0.0016
951 LUNG NEOPLASM MALIGNANT 66 0.0016
952 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 315 0.0016
953 SYSTEMIC LUPUS ERYTHEMATOSUS 54 0.0015
954 DEATH 1281 0.0015
955 C-REACTIVE PROTEIN INCREASED 53 0.0015
956 BREAST CANCER 134 0.0014
957 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 257 0.0014
958 OVERDOSE 305 0.0014
959 COMA 67 0.0014
960 LOWER RESPIRATORY TRACT INFECTION 63 0.0014
961 LIVER INJURY 34 0.0014
962 DRUG EXPOSURE DURING PREGNANCY 47 0.0014
963 LACTIC ACIDOSIS 44 0.0014
964 CEREBRAL INFARCTION 33 0.0013
965 NEOPLASM MALIGNANT 89 0.0013
966 THERAPEUTIC PRODUCT EFFECT DECREASED 59 0.0013
967 PANCREATIC CARCINOMA 38 0.0013
968 INTERSTITIAL LUNG DISEASE 62 0.0013
969 OSTEONECROSIS 42 0.0013
970 DEVICE LEAKAGE 52 0.0012
971 NEOPLASM PROGRESSION 40 0.0011
972 ILLNESS 113 0.0011
973 THERAPEUTIC RESPONSE SHORTENED 36 0.0011
974 PRODUCT DOSE OMISSION ISSUE 315 0.0011
975 PROSTATE CANCER 85 0.0011
976 COVID-19 185 0.0011
977 PRODUCT USE IN UNAPPROVED INDICATION 251 0.0010
978 DEVICE BREAKAGE 38 0.0009
979 SUICIDE ATTEMPT 56 0.0009
980 TOXICITY TO VARIOUS AGENTS 154 0.0009
981 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 53 0.0007
982 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 34 0.0007
983 MATERNAL EXPOSURE DURING PREGNANCY 56 0.0006
984 TREATMENT FAILURE 52 0.0006
985 ACCIDENTAL EXPOSURE TO PRODUCT 64 0.0006
986 DEVICE DIFFICULT TO USE 41 0.0006
987 NO ADVERSE EVENT 110 0.0006
988 BLADDER CANCER 33 0.0006
989 FOETAL EXPOSURE DURING PREGNANCY 45 0.0006
990 PRODUCT STORAGE ERROR 40 0.0005
991 COMPLETED SUICIDE 36 0.0004
992 DRUG DEPENDENCE 63 0.0004